Vici P - Search Results

1

Taxanes and gemcitabine doublets in the management of HER-2 negative metastatic breast cancer: towards optimization of association and schedule.

Metro G, Fabi A, Russillo M, Papaldo P, De Laurentiis M, Ferretti G, Pellegrini D, Nuzzo C, Graziano V, Vici P, Introna M, Felici A, Cognetti F, Carlini P. Metro G, et al. Among authors: vici p. Anticancer Res. 2008 Mar-Apr;28(2B):1245-58. Anticancer Res. 2008. PMID: 18505062 Free article. Review.

2

Combination chemotherapy with oral idarubicin and cyclophosphamide for metastatic breast cancer.

Lopez M, Vici P, Carpano S, Natali M, Ganzina F, Conti EM, Di Lauro L. Lopez M, et al. Among authors: vici p. J Cancer Res Clin Oncol. 1991;117(1):61-4. doi: 10.1007/BF01613198. J Cancer Res Clin Oncol. 1991. PMID: 1997473 Clinical Trial.

3

5-Fluorouracil, adriamycin, cyclophosphamide (FAC) vs. 5-fluorouracil, epirubicin, cyclophosphamide (FEC) in metastatic breast cancer.

Lopez M, Papaldo P, Di Lauro L, Vici P, Carpano S, Conti EM. Lopez M, et al. Among authors: vici p. Oncology. 1989;46(1):1-5. doi: 10.1159/000226671. Oncology. 1989. PMID: 2915887 Clinical Trial.

4

Intrapatient comparison of single-agent epirubicin with or without lonidamine in metastatic breast cancer.

Lopez M, Vici P, Di Lauro L, Paoletti G, Gionfra T, Conti F, Carpano S, Pignatti F, Giannarelli D. Lopez M, et al. Among authors: vici p. Eur J Cancer. 1995 Sep;31A(10):1611-4. doi: 10.1016/0959-8049(95)00200-3. Eur J Cancer. 1995. PMID: 7488410 Clinical Trial.

5

Prognostic value of lymph node metastases after neoadjuvant chemotherapy for large-sized operable carcinoma of the breast.

Botti C, Vici P, Lopez M, Scinto AF, Cognetti F, Cavaliere R. Botti C, et al. Among authors: vici p. J Am Coll Surg. 1995 Sep;181(3):202-8. J Am Coll Surg. 1995. PMID: 7670678

6

Sequential subcutaneous thymopentin, interferon alpha-2a and interleukin-2 in metastatic renal cell cancer.

Di Lauro L, Del Medico P, Carpano S, Cancrini A, Gionfra T, Vici P, Rosselli M, Lopez M. Di Lauro L, et al. Among authors: vici p. Tumori. 1995 Jan-Feb;81(1):42-4. doi: 10.1177/030089169508100110. Tumori. 1995. PMID: 7754540 Clinical Trial.

7

Combined treatment with buserelin and cyproterone acetate in metastatic male breast cancer.

Lopez M, Natali M, Di Lauro L, Vici P, Pignatti F, Carpano S. Lopez M, et al. Among authors: vici p. Cancer. 1993 Jul 15;72(2):502-5. doi: 10.1002/1097-0142(19930715)72:2<502::aid-cncr2820720228>3.0.co;2-1. Cancer. 1993. PMID: 8319180

8

Vinorelbine and mitomycin C in anthracycline-pretreated patients with advanced breast cancer.

Vici P, Di Lauro L, Carpano S, Amodio A, Pignatti F, Casali A, Conti F, Lopez M. Vici P, et al. Oncology. 1996 Jan-Feb;53(1):16-8. doi: 10.1159/000227528. Oncology. 1996. PMID: 8570125 Clinical Trial.

9

Paclitaxel activity in anthracycline refractory breast cancer patients.

Vici P, Di Lauro L, Conti F, Capomolla E, Gionfra T, Amodio A, Lopez M. Vici P, et al. Tumori. 1997 May-Jun;83(3):661-4. doi: 10.1177/030089169708300307. Tumori. 1997. PMID: 9267484 Clinical Trial.

10

European trials with dexrazoxane in amelioration of doxorubicin and epirubicin-induced cardiotoxicity.

Lopez M, Vici P. Lopez M, et al. Among authors: vici p. Semin Oncol. 1998 Aug;25(4 Suppl 10):55-60. Semin Oncol. 1998. PMID: 9768825 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

277 results

Search Page

Filters